Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Marketsthymosin alpha-1precision peptidetransdermal

Precision Peptide orders 20,000 thymosin alpha-1 patches for launch

The order covers initial commercial supply of a transdermal delivery format for the immune peptide.

TR
By Tom Reyes · Markets Editor
Oct 7 13:47 ETSource: StreetInsider

The wire

  1. 01Precision Peptide placed an order for 20,000 thymosin alpha-1 patches to support a product launch, according to the company announcement.
  2. 02Thymosin alpha-1 is normally given by injection, so a patch format would change how clinics and patients handle it.
  3. 03No clinical data, pricing, regulatory pathway or launch date is provided, and the figures come from the company itself.

From the source

Precision Peptide orders 20,000 Thymosin Alpha-1 patches for launch

Read at streetinsider.com
PeptiPrescribed peptides from $99/moSee all →